Avoid Product Promotion Landmines—Lessons Learned from 2014 FDA Warning and Untitled Letters and Key Upcoming Developments

Program Speakers

Elaine Tseng, Nikki Reeves, Gillian Russell

Description

Please join us for a review of key takeaways from FDA's 2014 drug promotion enforcement letters. Learn the issues that were most commonly cited in last year's FDA Warning and Untitled Letters, as well as key upcoming developments, and what these mean for your business. Topics to be covered include: (1) FDA enforcement overview, (2) most frequently cited issues, (3) emerging areas of interest and anticipated developments in 2015, including in social media, and (4) avoiding potential pitfalls in promotional materials.

You may register for the program here.

If you have questions that are not addressed during the program, please contact one of the speakers and they will be happy to answer them.

If you would like to receive CLE credit for this program, please complete this linked form and return to King & Spalding (see instructions on form).

Thank you for your interest in our e-Learn Series.  To send a request to have your name placed on the e-Learn invitation list, click here. 

Contact

Kristina Sooy
Professional Development Coordinator
King & Spalding LLP
1180 Peachtree Street NE
Atlanta, GA 30309
+1 404 572 3042 Direct
ksooy@kslaw.com